Details for Patent: 5,944,329
Summary for Patent: 5,944,329
| Title: | Reversible micromachining locator | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Abstract: | This invention provides a device which includes a locator, a kinematic mount positioned on a conventional tooling machine, a part carrier disposed on the locator and a retainer ring. The locator has disposed therein a plurality of steel balls, placed in an equidistant position circumferentially around the locator. The kinematic mount includes a plurality of magnets which are in registry with the steel balls on the locator. In operation, a blank part to be machined is placed between a surface of a locator and the retainer ring (fitting within the part carrier). When the locator (with a blank part to be machined) is coupled to the kinematic mount, the part is thus exposed for the desired machining process. Because the locator is removably attachable to the kinematic mount, it can easily be removed from the mount, reversed, and reinserted onto the mount for additional machining. Further, the locator can likewise be removed from the mount and placed onto another tooling machine having a properly aligned kinematic mount. Because of the unique design and use of magnetic forces of the present invention, positioning errors of less than 0.25 micrometer for each machining process can be achieved. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventor(s): | Leander J. Salzer, Larry R. Foreman | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assignee: | University of California San Diego UCSD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Application Number: | US08/925,096 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Patent Claim Types: see list of patent claims | Device; | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Patent landscape, scope, and claims: | United States Patent 5,944,329: Claim Scope, Validity, Expiration, and Patent LandscapeU.S. Patent No. 5,944,329 is not a drug patent. It covers a mechanical locator-and-mount apparatus for machining parts. The core invention combines a circumferential kinematic mount, alternating connection elements and grooves, and a reversible locator having projections that engage the grooves. The claims are directed to apparatus configurations rather than a method of machining, a particular workpiece, or a pharmaceutical product. The patent’s commercial relevance is primarily historical. Its claim set is narrow in geometry and component arrangement, and its U.S. patent term has likely expired based on the 1990s filing and 1999 grant chronology. No Orange Book listing, FDA exclusivity, Paragraph IV pathway, biosimilar issue, or drug-related regulatory status applies. What technology does U.S. Patent 5,944,329 protect?The patent protects a modular workholding system for positioning parts during machining. Its architecture has two principal components:
The mount uses grooves and connecting elements arranged around its circumference. The locator has projections on both of its opposing surfaces. The projections fit into the mount grooves, allowing the locator to be positioned with either surface facing the mount. The claims indicate that the system is intended to provide repeatable positioning while allowing rapid locator replacement or reorientation. The claimed apparatus also supports configurations in which two locators are placed on the same mount at the same time. What is the scope of independent claim 1?Claim 1 is the principal scope-defining claim. It requires every element below:
The claim is a combination claim. A device must contain the mount, locator, alternating circumferential arrangement, dual-sided projections, and projection-groove positioning relationship to fall within the literal scope of claim 1. A conventional fixture with only one-sided locating features would not satisfy the express requirement for projections on both locator surfaces. A system using a flat plate and independent dowel pins may also avoid literal infringement if it lacks the claimed alternating circumferential connection and groove arrangement. How do claims 2 through 11 narrow the patent scope?Claims 2 through 11 add specific hardware configurations.
These claims are progressively narrower. For example, a system using permanent magnets but ceramic or non-steel locating projections may potentially avoid claim 8 while remaining within claim 2, assuming all claim 1 elements are present. A mount with six V-grooves may fall within claim 6 but not claim 5, which requires three V-grooves. Claim 3 is narrower than claim 2 but does not necessarily require a particular rare-earth composition. The term “rare earth magnets” would ordinarily encompass commercially recognized rare-earth magnet types, subject to the specification and prosecution history. What do claims 12 through 16 protect?Claims 12 through 16 address dual-locator operation. Claim 12 requires a first locator and a second locator that are simultaneously disposed on the same mount. This is a significant narrowing limitation because the claim is directed to concurrent use rather than merely the capability of using multiple interchangeable locators. Claims 13 and 14 define the first locator. It must include:
Claim 14 specifies three of each principal feature, arranged at 120-degree intervals. Claims 15 and 16 define the second locator. The second locator must include:
Claim 16 specifies three of each feature, also arranged at 120-degree intervals. The distinction between the first and second locator configurations appears to concern the location and function of clearance holes. The claimed holes permit two locators to occupy the mount simultaneously without interference from magnets, projections, or bosses. What claim construction issues are likely to matter?The following terms would likely control infringement analysis: “Kinematic mount”A kinematic mount generally constrains a workpiece or fixture through defined contact points and repeatable geometric constraint. The claim does not merely require a flat support plate. The accused mount would likely need a structure that provides repeatable positioning through the claimed grooves and projections. “Alternating circumferentially”This language requires a circumferential sequence in which connection or receptive structures alternate with grooves. A mount where all magnets are grouped in one area and all grooves in another may not satisfy this limitation. “Projections on both locator surfaces”The requirement applies to both opposing locator surfaces. Projections on only the working face are insufficient for literal claim 1 infringement. “Either surface contacting said mount”The locator must be usable with either surface against the mount. This limitation supports the patent’s reversible-locator concept. “Connecting means” and “means receptive to a connecting means”These phrases may invoke means-plus-function analysis under 35 U.S.C. § 112(f), depending on the specification and prosecution history. If so, the corresponding structure disclosed in the patent and its equivalents would define the enforceable scope. The specification would be essential to determine whether the claims cover only magnets and magnetically attractive materials or broader connection technologies. “Part support means”Claims 10 and 11 identify examples of the support structure, but claim 1 is broader. A retainer ring or clamp is not necessarily required by the independent claim unless the dependent claim is asserted. What is the difference between literal infringement and the doctrine of equivalents?Literal infringement requires the accused apparatus to satisfy every limitation of the asserted claim. For claim 1, the most important literal questions would be:
The doctrine of equivalents could become relevant where an accused product uses a technically different structure that performs substantially the same function in substantially the same way to achieve substantially the same result. The “all elements” rule still applies. A substantial departure from the reversible dual-sided projection architecture could weaken an equivalence theory. How strong is the patent estate?The patent estate appears limited to a single U.S. patent and the claim set reproduced by the user. The claims are technically specific and structurally dense. That produces a mixed enforcement profile:
Claim 1 is broader than the dependent claims but still requires a particular combination of circumferentially alternating structures and reversible dual-sided projections. Competitors could design around the claims by changing the locating interface, eliminating reversible use, using non-circumferential positioning elements, or using a different retention mechanism. When did U.S. Patent 5,944,329 lose exclusivity?The patent was granted on August 31, 1999. Its exact expiration date depends on the applicable patent-term regime, the earliest effective nonprovisional filing date, any patent-term adjustment, and any terminal disclaimer. Because the patent originated from the 1990s, its term would ordinarily be calculated under the 20-year-from-effective-filing-date framework applicable to post-June 8, 1995 applications, unless an earlier priority or other term rule applies. A 1999 grant date alone does not establish the expiration date. The public patent record, including the front page, continuity data, and USPTO Patent Center, controls the final calculation. See 35 U.S.C. § 154 and USPTO, “Patent Term Calculator.” The practical business conclusion is that a 1999-issued mechanical patent of this vintage is no longer a normal current blocking right unless an unusual term adjustment or other legally operative circumstance extended its term. What is the FDA and Orange Book status?U.S. Patent 5,944,329 has no FDA or Orange Book status because it does not claim a drug, active pharmaceutical ingredient, formulation, method of treatment, dosage form, biologic, or manufacturing process for a regulated medicine.
The patent cannot block an ANDA, 505(b)(2) application, or biosimilar application because its claims are unrelated to a pharmaceutical product. What patent landscape surrounds the claimed technology?The relevant landscape is mechanical workholding and precision fixturing rather than drug patents. Competing technologies would likely fall into these categories: Kinematic and quasi-kinematic fixturesThese systems use defined contact points, balls, grooves, cones, pins, or other constrained interfaces to achieve repeatable repositioning. A competitor using a different contact geometry may avoid the specific projection-and-groove combination. Magnetic workholding systemsMagnetic bases and ferromagnetic locators are central to claims 2, 3, and 7. Relevant competing designs may use vacuum retention, mechanical clamps, pneumatic retention, hydraulic clamping, or mechanical fasteners. Modular fixture platesModular plates may support interchangeable nests, pallets, dowel systems, or locating blocks. A plate with fixed dowel-hole patterns may present a different claim profile from the circumferential alternating arrangement required by claim 1. Reversible locator systemsThe reversible feature is a central technical limitation. Systems with only one usable locator orientation may avoid the express dual-surface requirement. Multi-part or dual-locator fixturesClaims 12 through 16 focus on two locators used simultaneously. Competing systems may use separate independent mounts, linear indexing, stacked fixture plates, or non-overlapping nests. What manufacturing and intellectual-property barriers remain?The patent itself does not create a significant current manufacturing barrier if its U.S. term has expired. The principal barriers are likely engineering and commercial:
A manufacturer could still face rights under later patents, foreign counterparts, unexpired continuation patents, design patents, trade secrets, or third-party rights covering improved fixture geometries. Those rights cannot be determined from the supplied claims alone. Are there Paragraph IV challenges, settlements, or licensing deals?No pharmaceutical Paragraph IV analysis applies. The supplied claim set does not identify any generic-drug challenger, biosimilar applicant, FDA sponsor, Hatch-Waxman litigation, or drug patent settlement. A licensing assessment would require the patent’s assignment history, recorded licenses, security interests, litigation docket, and any related continuation or foreign-family filings. The claims alone do not establish whether the patent was licensed or commercially transferred. What geographic coverage does the patent provide?The patent claims provide U.S. rights only. Any protection outside the United States would require separately issued foreign patents or regional rights. A U.S. patent does not automatically create enforceable rights in Canada, Europe, Japan, China, or other jurisdictions. Foreign family members, if any, would require separate review for:
Key Takeaways
FAQsIs U.S. Patent 5,944,329 a pharmaceutical patent?No. It covers a locator and mount apparatus used to position parts during machining. Can a magnetic fixture infringe U.S. Patent 5,944,329?Potentially, but magnetic retention alone is insufficient. The fixture would also need to satisfy the applicable mount, groove, projection, circumferential arrangement, and reversible-locator limitations. Does a three-point kinematic mount automatically infringe the patent?No. Three-point geometry alone does not establish infringement. The accused system must satisfy all limitations of an asserted claim, including the claimed circumferential arrangement and dual-sided locator projections. Do claims 12 through 16 cover any two fixtures used together?No. They require specific first and second locator structures, including projections, offset bosses, clearance holes, and, in the narrower claims, three-part 120-degree arrangements. Is a Paragraph IV certification required to challenge this patent?No. Paragraph IV certifications apply to patents listed for approved drug products. This patent is directed to mechanical machining equipment and has no Orange Book function. Sources:
More… ↓ |
Drugs Protected by US Patent 5,944,329
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
